CN Stock MarketDetailed Quotes
688089 Cabio Biotech(Wuhan)
- 17.84
- -0.94-5.01%
Market Closed Jan 3 15:00 CST
3.00BMarket Cap26.16P/E (TTM)
18.97High17.81Low23.91KlotVolume18.88Open18.78Pre Close43.75MTurnover1.42%Turnover Ratio32.85P/E (Static)168.31MShares30.1252wk High1.97P/B3.00BFloat Cap9.7852wk Low22.54Limit Up168.31MShs Float48.85Historical High15.02Limit Down6.18%Amplitude9.78Historical Low0.20Dividend TTM18.30Avg Price13.11KlotAsk1.12%Div YieldTTM100Lot Size9.49KlotBid
Cabio Biotech(Wuhan) Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 30.55%414.96M | 28.27%287.5M | 7.18%120.54M | -1.18%437.07M | 8.81%317.85M | 11.54%224.13M | 8.80%112.47M | 29.47%442.28M | 31.57%292.11M | 40.91%200.94M |
| Refunds of taxes and levies | --414.78K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | -3.50%41.08M | -0.93%37.03M | -16.89%26.58M | -14.66%48.06M | -14.28%42.57M | -14.37%37.38M | -23.64%31.98M | 7.93%56.31M | 9.11%49.66M | 1.71%43.65M |
| Cash inflows from operating activities | 26.65%456.46M | 24.10%324.53M | 1.85%147.12M | -2.70%485.13M | 5.46%360.42M | 6.92%261.51M | -0.77%144.45M | 26.61%498.6M | 27.75%341.77M | 31.84%244.59M |
| Goods services cash paid | 3.06%203.16M | -27.76%103.82M | -41.35%53.55M | 30.05%228.65M | 33.78%197.13M | 78.18%143.71M | 149.91%91.3M | 28.32%175.82M | 44.93%147.35M | 21.47%80.65M |
| Staff behalf paid | 6.97%70.64M | 8.45%49.77M | 6.25%27.35M | 15.29%87.8M | 14.12%66.04M | 13.91%45.9M | 5.20%25.74M | 11.56%76.15M | 14.48%57.87M | 10.65%40.29M |
| All taxes paid | -22.27%29.79M | -32.26%19.52M | -46.20%8.49M | 84.23%49.04M | 107.99%38.32M | 197.03%28.82M | 259.38%15.78M | -32.69%26.62M | -44.95%18.43M | -56.91%9.7M |
| Cash paid relating to other operating activities | 39.42%47.06M | 17.59%27.21M | -15.17%14.35M | 16.39%50.75M | -2.50%33.75M | -1.47%23.14M | 6.80%16.91M | -4.54%43.61M | 21.68%34.62M | 19.99%23.48M |
| Adjustment items of operating cash outflws | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from operating activities | 4.60%350.65M | -17.07%200.32M | -30.72%103.73M | 29.19%416.24M | 29.81%335.25M | 56.73%241.56M | 84.34%149.73M | 10.91%322.19M | 20.60%258.27M | 6.38%154.13M |
| Net cash flows from operating activities | 320.30%105.81M | 522.63%124.21M | 920.70%43.39M | -60.95%68.89M | -69.85%25.17M | -77.95%19.95M | -108.22%-5.29M | 70.78%176.4M | 56.45%83.5M | 122.69%90.46M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -93.30%17.38M | -89.97%24M | ---- | ---- | -55.68%259.27M | -17.49%239.27M | ---- | ---- | 104.84%585M | -30.22%290M |
| Cash received from returns on investments | -88.45%497.19K | -94.07%197.26K | -93.42%136.6K | -13.75%7.49M | -49.98%4.31M | -38.66%3.32M | -31.40%2.08M | -25.89%8.69M | -26.90%8.61M | -36.21%5.42M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 40.39%182.26K | -10.91%89.55K | 404.18%55.71K | 68.77%269.65K | 29.40%129.82K | 559.89%100.51K | --11.05K | -16.73%159.78K | -18.60%100.33K | -87.18%15.23K |
| Cash received relating to other investing activities | ---- | ---- | -43.49%90M | -51.10%252.8M | ---- | ---- | -50.23%159.27M | -14.66%517M | ---- | ---- |
| Cash inflows from investing activities | -93.15%18.06M | -89.99%24.29M | -44.10%90.19M | -50.45%260.56M | -55.58%263.71M | -17.85%242.7M | -50.05%161.36M | -14.88%525.85M | 99.58%593.71M | -30.36%295.44M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -27.81%152.85M | -31.82%86.3M | -18.24%51.64M | 19.33%297.68M | 28.47%211.72M | 5.39%126.57M | -21.32%63.16M | 43.84%249.47M | 63.22%164.8M | 169.74%120.1M |
| Cash paid to acquire investments | -70.74%77.97M | -73.73%70M | ---- | -59.86%30.15M | -63.06%266.5M | -42.07%266.5M | -1.18%19.98M | -15.47%75.11M | 10.14%721.5M | -24.04%460M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | -61.54%25M | -61.54%25M | ---- | ---- | 86.37%65.01M | 86.37%65.01M |
| Cash paid relating to other investing activities | ---- | ---- | -30.29%130M | -59.24%220.03M | ---- | ---- | -54.51%186.5M | -10.90%539.8M | ---- | ---- |
| Cash outflows from investing activities | -54.13%230.81M | -62.61%156.3M | -32.64%181.64M | -36.62%547.86M | -47.10%503.22M | -35.19%418.07M | -47.18%269.64M | -0.43%864.38M | 20.28%951.31M | -5.82%645.11M |
| Net cash flows from investing activities | 11.17%-212.75M | 24.73%-132.01M | 15.55%-91.45M | 15.13%-287.3M | 33.02%-239.52M | 49.85%-175.38M | 42.24%-108.29M | -35.21%-338.53M | 27.53%-357.6M | -34.08%-349.67M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --22.92M | 348.62%15.39M | 455.50%10.89M | ---- | ---- | --3.43M | --1.96M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --16.53M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | 113.17%21.32M | 76.45%8.82M | 0.00%5M | -63.33%11M | -66.67%10M | --5M | --5M | 0.00%30M | --30M | ---- |
| Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --50M | --50M |
| Cash inflows from financing activities | -16.03%21.32M | -44.47%8.82M | 0.00%5M | 13.06%33.92M | -69.57%25.39M | -69.42%15.89M | 155.10%5M | -4.67%30M | --83.43M | --51.96M |
| Borrowing repayment | -50.00%15M | -83.33%5M | --5M | --30M | --30M | --30M | ---- | ---- | ---- | ---- |
| Dividend interest payment | -6.99%33.91M | 9,565.80%33.81M | -63.66%96.35K | -8.19%36.58M | -9.15%36.46M | -34.56%349.77K | --265.17K | -0.06%39.85M | 1.35%40.13M | --534.51K |
| Cash payments relating to other financing activities | -54.49%466.8K | -70.42%303.4K | ---- | 37.13%1.35M | -97.95%1.03M | --1.03M | ---- | 1.70%985.91K | --50M | ---- |
| Cash outflows from financing activities | -26.83%49.38M | 24.66%39.11M | 1,821.94%5.1M | 66.38%67.94M | -25.12%67.49M | 5,769.89%31.38M | --265.17K | -42.36%40.83M | 127.61%90.13M | --534.51K |
| Net cash flows from financing activities | 33.34%-28.06M | -95.57%-30.29M | -102.03%-96.35K | -214.07%-34.02M | -527.96%-42.1M | -130.12%-15.49M | 141.57%4.73M | 72.49%-10.83M | 83.07%-6.7M | --51.43M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -54.30%941.52K | -6.31%1.49M | 129.03%255.12K | -79.19%1.46M | -71.13%2.06M | -68.82%1.59M | -31.99%-878.74K | 487.37%7.02M | 1,821.09%7.13M | 958.00%5.11M |
| Net increase in cash and cash equivalents | 47.30%-134.07M | 78.38%-36.6M | 56.34%-47.9M | -51.24%-250.96M | 7.05%-254.39M | 16.46%-169.32M | 9.95%-109.72M | 11.86%-165.94M | 43.00%-273.67M | 8.19%-202.68M |
| Add:Begin period cash and cash equivalents | -51.15%239.68M | -51.15%239.68M | -50.69%239.68M | -25.27%490.64M | -25.27%490.64M | -25.27%490.64M | -25.96%486.1M | -22.28%656.58M | -22.28%656.58M | -22.28%656.58M |
| End period cash equivalent | -55.30%105.61M | -36.80%203.07M | -49.05%191.77M | -51.15%239.68M | -38.30%236.25M | -29.21%321.32M | -29.61%376.38M | -25.27%490.64M | 4.98%382.91M | -27.27%453.89M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
